Literature DB >> 15224265

Assessing competence to complete psychiatric advance directives with the competence assessment tool for psychiatric advance directives.

Debra Srebnik1, Paul S Appelbaum, Joan Russo.   

Abstract

The Competence Assessment Tool for Psychiatric Advance Directives (CAT-PAD), a new instrument designed to assess competence to complete a psychiatric advance directive (PAD), is described. Initial psychometric properties and data regarding participant performance on the instrument are detailed. Study participants were 80 outpatients with at least two psychiatric crises in the previous 2 years. The CAT-PAD has three scales that assess decisional capacities regarding the nature and value of PADs and a specific treatment choice: Understanding, Appreciation, and Reasoning. Construct and discriminant validity were evaluated using the AD-Maker competence questions, symptom and functioning scales, and clinical and demographic characteristics. Reliability was strong for the Understanding and Reasoning scales and total score, and adequate for the Appreciation scale. Construct validity was demonstrated in relation to the AD-Maker competence questions and scales assessing psychotic symptoms. The CAT-PAD was generally unbiased with respect to gender, ethnicity, and age. Controlling for psychotic symptoms, diagnosis was not significantly related to CAT-PAD scores. Most participants performed well on the CAT-PAD. Using rigid cutoffs for the CAT-PAD is not advised due to lack of consensus on the degree of capacities required for completing a PAD, and differences in situational demands. Routine screening using the CAT-PAD is also not recommended, but rather assessment is suggested when a priori doubts exist about a person's decisional capacity. Such use of the CAT-PAD may allow clinicians to better trust the content of PADs, which may, in turn, increase the likelihood PADs will be honored.

Entities:  

Keywords:  Empirical Approach; Mental Health Therapies

Mesh:

Year:  2004        PMID: 15224265     DOI: 10.1016/j.comppsych.2004.03.004

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  8 in total

1.  Origination of medical advance directives among nursing home residents with and without serious mental illness.

Authors:  Xueya Cai; Peter Cram; Yue Li
Journal:  Psychiatr Serv       Date:  2011-01       Impact factor: 3.084

Review 2.  Psychiatric advance directives and social workers: an integrative review.

Authors:  Richard A Van Dorn; Anna Scheyett; Jeffrey W Swanson; Marvin S Swartz
Journal:  Soc Work       Date:  2010-04

3.  Competence to complete psychiatric advance directives: effects of facilitated decision making.

Authors:  Eric B Elbogen; Jeffrey W Swanson; Paul S Appelbaum; Marvin S Swartz; Joelle Ferron; Richard A Van Dorn; H Ryan Wagner
Journal:  Law Hum Behav       Date:  2007-06

4.  Facilitated psychiatric advance directives: a randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness.

Authors:  Jeffrey W Swanson; Marvin S Swartz; Eric B Elbogen; Richard A Van Dorn; Joelle Ferron; H Ryan Wagner; Barbara J McCauley; Mimi Kim
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

5.  EFFECTIVELY IMPLEMENTING PSYCHIATRIC ADVANCE DIRECTIVES TO PROMOTE SELF-DETERMINATION OF TREATMENT AMONG PEOPLE WITH MENTAL ILLNESS.

Authors:  Eric B Elbogen; Richard Van Dorn; Jeffrey W Swanson; Marvin S Swartz; Joelle Ferron; H Ryan Wagner; Christine Wilder
Journal:  Psychol Public Policy Law       Date:  2007-11

6.  Reducing barriers to completing psychiatric advance directives.

Authors:  Richard A Van Dorn; Jeffrey W Swanson; Marvin S Swartz; Eric Elbogen; Joelle Ferron
Journal:  Adm Policy Ment Health       Date:  2008-07-17

7.  Covert treatment in psychiatry: do no harm, true, but also dare to care.

Authors:  Ajai R Singh
Journal:  Mens Sana Monogr       Date:  2008-01

8.  Advance Decision Making in Bipolar: A Systematic Review.

Authors:  Lucy A Stephenson; Tania Gergel; Astrid Gieselmann; Matthé Scholten; Alex Ruck Keene; Larry Rifkin; Gareth Owen
Journal:  Front Psychiatry       Date:  2020-10-16       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.